Germany’s healthcare corporations Merck Serono has allotted 10 million Euros to an incubator for new Israeli companies at its Inter-Lab R&D center in Yavne. The latest startups to join are Chanbio (MS antibody treatment) and Metabomed (cancer metabolism).
http://www.globes.co.il/serveen/globes/docview.asp?did=1000901878